Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Keith I'm hopeful a buyout is in the works but realistically I could see a sale price in the $500-$600m range/$10-$12. While we all think the science is worth more, the company has been so poorly managed and lost investor confidence that it's not exaclty in a position if negotiating strength. One has to look no further than the $2 offering for 20% of the company. I think we should be able to get $500-$600m base on the NEO deal, AXAL, HOT and PSA. The only way I could see up toward $1b or more is if Amgen is bidding against another interested company and Amgen doesn't want anyone to have HOT and pays up.